The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Try the newly designed Company Pages!
Switch now

Merus Labs International

  • MSL
  • TSX
  • Consumer Products
  • Latest 2.65
  • Currency C$
  • Change 0.09
  • Percent Change 3.516 %
  • Volume 1,135,045
  • Thu Jul 31, 2014 03:59 PM EDT TSX data delayed 15 minutes.
  • Open 2.58
  • Previous Close 2.56
  • High 2.68
  • Low 2.35
  • Bidx3,000 2.63
  • Askx7,600 2.65
  • 52-week High07/31 2.68
  • 52-week Low08/09 0.87
  • Beta 0.631
  • Market Cap 137.59M
  • EPS -0.11
  • P/E
  • Forward P/E 20.38
  • PEG
  • Annual Dividend 0.0000
  • Yield

News

Financials & Calendars

Income Statement

  • Sales $28,037,914
  • Earnings $-4,441,918
  • Return on Equity n/a

Cash Flow

  • Cash Flow $9,576,714
  • Cash $31,695,978
  • Current Ratio 2.97

12 months ended Mar 31, 2014.

Trailing 12 month results shown above.
All data is in Canadian dollars.

Balance Sheet

  • Assets $108,141,605
  • Liabilities $39,067,598
  • Liabilities-to-Equity Ratio 0.57

Price Ratios

  • Price to Sales 3.71
  • Price to Book 1.51
  • Price to Cash Flow 10.88

Event Calendar

Event Last   Next  
Earnings May 13 $0.01 Aug 12 $0.01
Surprises May 13 -500.00% n/a n/a
Dividends n/a n/a n/a n/a
Splits n/a -- n/a n/a

12 months ended Jul 31, 2014.

A look at major corporate events and financial announcements that are coming up.

Company Information

About the Company

MERUS LABS INTERNATIONAL INC. is a pharmaceutical company. It is engaged in the acquisition and licensing of branded prescription pharmaceutical products. It has products in in the area of urology/women's health, anti-infective, and wound care.

Related Securities
Symbol Type Latest % Chg

Officers

  • Elie Farah President & C.E.O.
  • Andrew Patient C.F.O.
  • Company Type: PUBLIC
  • Company Status: Active
  • Full-time Employees: n/a
  • Incorporation: Canada,
    n/a
  • Top 1000 Ranking: Profit: 851
    Revenue: 742
    Assets: 742

Head Office

100 Wellington St. West
Toronto, ON
M5K 1H1

Phone: (416)-593-3725
Fax: (416)-5934434

efarah@meruslabs.com
www.meruslabs.com

Ideas & Discussion

Live Discussion of MSL on StockTwits
The Globe and Mail has
updated our Company Pages
Switch to the newly designed Company Pages format today for a more in-depth look at the companies you're following and pages that are easier to navigate. If you prefer the old layout after trying the new Company Pages, you can switch back anytime.